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Abstract

DOSAGE WINDOW OF SELENIUM ON HUMAN NATURAL KILLER
CYTOTOXICITY AND NEUTROPHILMEDIATED CHEMILUMINESCENCE
by
Mary LaBue

Few studies have been conducted on the effect of in vitro selenium
(Se) supplementation on cellular immunity.

In the present study, the

effects of in vitro incubation with sodium selenite on natural killer
(NK)-mediated cytotoxicity and phagocyte chemiluminescence (CL) were
examined.

NK-mediated cytotoxicity and phagocyte CL were observed to

be affected by added selenite.

These changes generally included

augmentation and suppression of both neutrophil CL and NK-mediated
cytotoxicity.

All dosages of selenite used were shown to be capable of

causing augmentation of neutrophil CL.

However, 1.0 /xg/ml selenite was

also observed to occasionally cause depression of neutrophil CL.

When

Se supplementation enhanced NK cytotoxicity, the effect was always
observed at 0.1 /xg/ml selenite dosage.

Higher dosages of selenite

induced both enhancement and depression of activity.

The existence of

a narrow dosage-window is evident.
The activity of the selenoenzyme glutathione peroxidase (GSH-Px)
was also determined in NK cells and phagocytes following selenite
supplementation.

Dose-dependent augmentation of phagocytic activity by

selenite supplementation was accompanied by a corresponding increase in

phagocyte GSH-Px activity.

The effect of Se treatment on non-adherent

cell GSH-Px activity did not correlate with NK cytotoxicity.
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Introduction

Selenium (Se) is an essential trace element which influences the
immune response and host defense mechanisms (1-7).

At nutritional

levels, Se possesses a broad spectrum of anticarcinogenic (8-12) and
antimutagenic activity (13-17).

Epidemiological data suggest that

adequate dietary levels of Se are associated with a decreased risk of
developing cancer while deficiency may be related to an increased
cancer risk (18-21).

The immune system mediates an array of cytotoxic

mechanisms intimately involved in the surveillance against neoplastic
disease.

Several studies suggest that adequate levels of nutritional

Se are required for the optimal functioning of various components of
the immune system, such as the humoral immune response (22,23), natural
killer (NK) cell-mediated cytotoxicity (3,5,6,7) as well as
polymorphonuclear leukocyte (PMN) function (1,2,24).

Se deficiency in

cows (24) and goats (1,2) is associated with impaired phagocytic
function.

NK cytotoxicity has been shown to be enhanced by dietary Se

supplementation in rats and humans (3,5,7).

The role of Se in the

microbicidal activity of phagocytes is perhaps the best studied.

It

has been widely suggested that glutathione peroxidase (GSH-Px), a
selenium-containing enzyme, is central in this regard.
leads to decreased activity of phagocyte GSH-Px (1,25).

Se deficiency
This enzyme

appears to be involved in protecting phagocytes against deleterious
effects of hydrogen peroxide (H2O2) generated in association with
superoxide (0_2), singlet oxygen (^C^) and hydroxyl radicals (OH*) (2627).

These toxic reactive oxygen species mediate the microbicidal

activity associated with phagocytosis (28).
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The involvement of GSH-Px
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on Se-modified NK activity has also been suggested but not evaluated
(3).
Few of the published studies have been conducted in vitro, where
valuable information regarding the cellular mechanisms of Se-modified
immunosurveillance might be obtained.

Dimitrov et al. (3) failed to

demonstrate enhancement of NK activity with the in vitro addition of
Se, though enhancement was demonstrated in corresponding in vivo
studies.

Watson et al. (29) could only demonstrate depression of NK

activity at relatively high levels of Se.

Virtually all studies of the

effect of Se on phagocytic function involve dietary experiments where
Se was given orally and phagocytic function and GSH-Px activity were
subsequently evaluated in the peripheral blood.

The present study

examined the effect of in vitro Se supplementation on NK cytotoxicity,
neutrophil chemiluminescence (CL) and the intracellular GSH-Px activity
of neutrophils and NK cells.

Materials and Methods
Normal Volunteers.

This study was carried out using peripheral

blood obtained from seven healthy volunteers (24 to 50 years old) of
both sexes (four males and three female).
supplements.

Only one had taken selenium

Informed consent was obtained from each volunteer before

the beginning of the study.

The study was approved by the

Institutional Review Board for Human Studies.

No volunteer contributed

more that 50 ml of blood during any monthly period.
Lymphocyte Preparation.

Venous blood samples were collected by

appropriate venipuncture into vacutainer tubes containing heparin
(Becton-Dickinson, Rutherford, NJ).

Mononuclear cell were prepared

from heparinized blood samples by Ficol-Hypaque (Pharmacia Fine
Chemicals, Piscataway, NJ) density gradient centrifugation.

The cells

were washed twice in Hanks Balanced Salt Solution (HESS) and suspended
in tissue culture medium consisting of RPMI-1640 with 10% fetal calf
serum (FCS), 1000 units/ml penicillin and 375 units/ml streptomycin
(designated as TC medium henceforth).

Phagocytes were removed from the

lymphocytes by incubation for 20 minutes at 37°C in an atmosphere of 5%
CO2 in plastic petri dishes (Becton Dickinson Labware, Oxnard, CA).
The non-adherent lymphocytes were collected, washed and contaminating
erythrocytes lysed with potassium bicarbonate-ammonium chloride buffer
(ACK lysing buffer).

The resulting erythrocyte-free cells were

resuspended to the desired concentration in TC medium.

Viability of

these cells was greater than 95% by trypan blue exclusion.
Neutrophil Preparation.

Polymorphonuclear leukocytes (PMNs) were

isolated and purified from heparinized whole blood by density gradient
centrifugation using Neutrophil Isolation Medium (United Technologies
3
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Packard, Downers Grove, IL) followed by lysis of contaminating
erythrocytes with ACK-lysing buffer.

Cell suspensions thus prepared

contained greater than 98% PMN and viability assessed by trypan blue
exclusion was in excess of 99%.

After purification, the PMNs were

suspended in Medium 199 without indicator supplemented with 20% heat
inactivated PCS, 550 ng/ml heparin, 1000 units/ml penicillin and 375
units/ml streptomycin.
Natural Killer Cell Activity.

Non-adherent cells were suspended in

TC medium and their concentrations were adjusted to ultimately
obtain 100:1 and 50:1 effector:target ratios.

The target cells (K-

562), a human erythroleukemia cell line, were grown as stationary
suspension cultures in TC medium supplemented with 1 mM sodium
pyruvate.

These cells were labeled with 100-200 /iCi/ml of chromium-51

as sodium chromate (New England Nuclear Research Products, Boston, MA)
per 2-5 x 10^ cells/ml at 37°C in 5% CO2 for 2 hours.

They were washed

four times in TC medium and resuspended to 5 x 10^ cells/ml.

Viability

was determined by trypan blue exclusion and found to be greater than
95%.

Labeled K-562 cells were added in 100 /xl aliquots to the

appropriate wells of 96-well flat-bottom microtiter plates (Corning
Glass Works, Corning, NY) containing 100 /il of varying concentrations
of effector cells.

100 /xl of sodium selenite solutions were then added

to appropriate wells at concentrations adjusted to obtain final
concentrations of 0.1, 0.5 and 1.0 /zg/ml, respectively.
performed in triplicate.

All tests were

After centrifugation at 1000 rpm for 2

minutes, the plates were incubated at 37°C in 5% CO2 for 4 hours.
After incubation, supernatants were harvested using a Skatron
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Supernatant Collection System (Skatron Inc., Sterling, VA) and
radioactivity counted in a TM Analytic Gamma Trac 1193 gamma counter
(TM Analytic, Elk Grove Village, IL).

Percent cytotoxicity was

calculated as follows:
% cytotoxicity =

Experimental Release
X 100
Maximum Release

where maximum release represents target cells that were lysed with 10%
sodium dodecyl sulfate (SDS).

The 50:1 ratio was determined to give

the most consistent results and subsequently was used throughout this
s tudy.
Chemiluminescence (CL) Determination of Phagocytosis.
PMNs were divided into four aliquots.

Isolated

The control aliquot was pre-

incubated without sodium selenite in siliconized glass tubes for 30
minutes at 37°C in 5% CO2.

The experimental aliquots were handled

similarly except sodium selenite dissolved in HESS was added before
pre-incubation to obtain final concentrations of 0.1, 0.5 and
1.0 /ig/ml, respectively.

The chemiluminescent response of the

pretreated cells was used as a measure of reactive oxygen species
production and assayed at 37°C in a luminometer (Picolite model 6500,
Packard Instrument Co., Downers Grove, IL) interfaced with a PCcompatible computer for data acquisition and processing.
luminometry experiments were performed in triplicate.

All

Briefly,

pretreated PMNs were added to 55 x 12 mm plastic luminometry tubes (Los
Alamos Diagnostics, Los Alamos, NM) such that each tube contained
5 x 10^ cells in a total volume of 50 /xl.
transferred to the luminometer.

The tubes were then

The assay was initiated by the

addition of 150 /xl of an opsonized zymosan A suspension containing
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luminol (ZAP TM , Los Alamos Diagnostics).

The photon emission from each

sample was counted every 3 minutes over the course of 30 minutes.
Following the assay, the area under each curve representing light
emission versus time was calculated and reported as integrated photon
emission (30).
Glutathione Peroxidase Determination.

Isolated neutrophils were

prepared and treated with sodium selenite as previously described.
Isolated lymphocytes were divided into four aliquots and treated with
sodium selenite as described for phagocytes.

After incubation, the

cells were washed twice with potassium phosphate buffer (31) and
resuspended in 2 ml to a concentration between 5 x 10^ and 1 x 10^
cells/ml.

All samples were then sonicated (Branson Sonifier Cell

Disrupter 200, Danbury, CT) in the cold with four 10 second pulses,
then centrifuged at 10,000 rpm for 20 minutes at 4°C in a Sorvall RC-5C
Refrigerated Centrifuge (Sorvall Instruments, Wilmington, DL).

The

supernatant was removed for GSH-Px and protein determinations.
GSH-Px was measured using the spectrophotometric method developed
by Paglia and Valentine (32) as modified by Levander et al. (31).

The

absorbance was read in a Spectronic 1001 (Baush and Lomb, Rochester,
NY) before the reaction was initiated with t-butyl hydroperoxide and at
subsequent 1 minute intervals.

Absorbance change from 0 to 5 minutes

was used to calculate enzyme activity.

One enzyme unit is equal to

1 /imole NADPH oxidized per minute and is expressed as /xmoles NADPH
oxidized/min/mg/ml protein.
Protein Determination.

Protein concentrations of cell sonicates

were determined using a spectrophotometric method (33).

Briefly, cell
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sonicate was pipetted into a quartz cuvette and its absorbance was read
at 280 run and 260 ran in a Spectronic 1001.

Protein concentration was

then calculated as follows:

[Protein] = A28o/A260 X F X 1/d,

where A280 is absorbance at 280 ran, A26O is absorbance at 260 ran, F is
a conversion factor and d is the 1 cm pathlength.
Statistical Analysis.

Data were evaluated using either one-way

analysis of variance and Tukey's HSD (honestly significant difference)
test for multiple comparisons or Student's two-tailed t-test.

All

statistical procedures were performed with Statgraphics software
version 2.1 (STSC, Inc., Rockvill, MD).

P < 0.05 was used for the

significance level in Tukey's HSD procedure.

Results
Effect of Selenite on Neutrophil CL.

The in vitro addition of

sodium selenite to normal human phagocytes caused alterations of
phagocytic activity as measured by CL.

Table 1 shows the results with

samples obtained from seven subjects at various time intervals.

All

dosages of selenite used induced significant enhancement of CL in
samples 2 and 3.

0.1 and 0.5 /xg/ml selenite caused significant

enhancement of CL in sample 1.
suppression of activity.

However 1.0 /ig/ml selenite induced a

Samples 7,9 and 10 showed no changes in CL

with the addition of 0.1 and 0.5 /ig/ml selenite but enhancement with
the addition of 1.0 /xg/ml selenite.

Significant suppression of CL upon

the addition of 1.0 /jg/ml selenite was also observed in sample 4 but
the addition of the two lower dosages of selenite used did not induce
any change.

Samples 5,6,8 and 11 exhibited no significant change in CL

upon the addition of all selenite dosages used.
Figures 1-5 illustrate the five patterns of CL exhibited in
response to added selenite.

The five patterns are characterized by:

enhancement of CL with all three dosages of sodium selenite (Figure 1),
enhancement of CL with 0.1 and 0.5 Mg/ml selenite but depression with
1.0 /xg/ml selenite (Figure 2), no effect on CL with the addition of 0.1
and 0.5 jig/ml selenite but enhancement with 1.0 fig/val selenite (Figure
3), no effect with 0.1 and 0.5 ng/ral selenite and depression with 1.0
/ig/ml selenite (Figure 4) and finally, no significant effect with all
three dosages of selenite (Figure 5).
Effect of Selenite on Natural Killer Activity.

The effect of

sodium selenite on NK cytotoxicity in vitro is shown in Table 2.
Samples were obtained from five subjects at various time intervals.
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Seven of the twelve samples exhibited significant enhancement upon
addition of 0.1 /xg/ml selenite.

Four of the samples exhibited

enhancement of cytotoxicity upon addition of 0.5 /xg/ml selenite, while
three samples exhibited depression of activity at this dosage.
Addition of 1.0 /xg/ml selenite induced enhancement of activity in two
samples and depression in three samples.

All three concentrations of

selenite used were found to be non-toxic to K-562 tumor target cells.
Figure 6 illustrates six patterns of NK cytotoxic responses to
selenite.

Enhancement of activity with all three dosages of selenite

characterized the first response.

Enhancement of activity with 0.1 and

0.5 /xg/ml of selenite but no significant changes with 1.0 /zg/ml of
selenite characterized the second response.

The third response

appeared as enhancement with 0.1 /ig/ml of selenite and no changes with
0.5 and 1.0 /xg/ml of selenite.

The fourth response was characterized

by enhancement of activity with 0.1 /ug/ml of selenite and suppression
with 0.5 and 1.0 /ig/ml.

The fifth response appeared as no changes in

activity with 0.1 /ig/ml of selenite but suppression with 0.5 and 1.0
/ig/ml.

No significant changes in activity with the addition of all

dosages of selenite characterized the sixth response.
Effect of Selenite on GSH-Px Activity.

CL and GSH-Px activity were

simultaneously evaluated and the results are shown in Table 3.
Selenite supplementation in samples 1-4 induced similar changes in both
neutrophil CL and GSH-Px activity.
increase in GSH-Px was observed.

When Se enhanced CL, a concomitant
Reciprocally, when Se had no effect

on CL, as in sample 5, no alteration in GSH-Px could be discerned.
GSH-Px activity was evaluated in samples of non-adherent cells used

10
in the NK cytotoxicity assays.

The effect of Se supplementation on

GSH-Px activity did not correlate with NK activity.

(Data not shown).
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Table 1
EFFECT OF SELENITE ON CHEMILUMINESCENCE

Subject
#

Sample
#

Selenite Dosage
Control

0.1 /xg/ml

0.5 /zg/ml

1.0 /zg/ml

Integrated Photon Emission x 10^ ± SEM
1

1

3.47 ± 0.24

4.63 ± 0.38*

4.17 ± 0.17*

2.78 ± 0.04t

2

1.20 ± 0.14

1.71 ± 0.03*

1.56 ± 0.08*

1.61 ± 0.03*

3

2.74 ± 0.19

3.40 ± 0.16*

3.73 ± 0.17*

3.24 ± 0.04*

4

4.82 ± 0.80

4.55 ± 0.41

5.49 ± 0.30

2.22 ± 0.10t

5

3.33 ± 0.25

3.14 ± 0.44

3.07 ± 0.10

3.26 ± 0.02

6

1.37 ± 0.16

1.57 ± 0.03

1.53 ± 0.08

1.51 ± 0.02

3

7

6.63 ± 0.12

6.84 ± 0.15

6.98 ± 0.09

7.43 ± 0.06*

4

8

8.17 ± 0.01

8.69 ± 0.02

8.58 ± 0.02

9.00 ± 0.04

5

9

53.0 ± 0.04

54.8 ± 0.02

54.1 ± 0.01

58.6 ± 0.05*

6

10

35.8 ± 0.01

33.8 ± 0.03

34.2 ± 0.03

38.9 ± 0.03*

7

11

73.3 ± 0.04

79.0 ± 0.03

76.2 ± 0.04

78.0 ± 0.02

2

»

»

m

0

i

Significant increases (p<0.05) in activity; T significant suppression
(p<0.05) in activity; determined by Tukey's HSD test.
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Table 2
EFFECT OF SELENITE ON NK CYTOTOXICITY

Subject
#

Sample
#

Selenite Dosage
Control

0.1 /ig/ml

0.5 ng/ml

1.0 /ig/ml

% Cytotoxicity ± SEMa

1

2

3

4

5

1

69.8 ± 2.63

81.6 ± 1.45*

74.1 ± 6.10*

71.3 ± 1.00

2

73.5 ± 2.45

82.2 ± 2.70

74.8 ± 3.30

74.0 ± 4.50

3

44.8 ± 1.35

57.3 ± 2.90*

59.1 ± 1.70*

56.6 ± 2.85*

4

45.7 ± 1.00

47.2 ± 0.01

39.0 ± 7.10

39.6 ± 0.40

5

49.8 ± 1.55

54.2 ± 2.36*

46.3 ± 0.86

49.3 ± 1.66

6

53.2 ± 1.56

67.5 ± 2.00*

61.0 ± 4.25*

58.5 ± 6.50

7

64.7 ± 0.05

69.0 ± 0.32*

63.9 ± 0.20t

64.0 ± O.iot

8

37.2 ± 1.30

52.1 ± 1.15*

49.2 ± 2.75*

50.4 ± 1.15*

9

52.4 ± 0.80

45.6 ± 0.50

43.4 ± 4.25t

39.4 ± 3.00t

10

48.1 ± 1.72

50.9 ± 1.65

47.9 ± 0.47

52.5 ± 0.21

11

43.5 ± 0.45

54.9 ± 1.95*38.6 ± 1.95t

37.4 ± l.iot

12

35.3 ± 2.75

41.2 ± 0.35

33.7 ± 0.65

38.5 ± 1.75

a50:l cell ratio used.
•
• •
•
Significant increase (p<0.5) in activity as determined by
Tukey's HSD test.
tSignificant decrease (p<0.5) in activity as determined by
Tukey's HSD test.
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Table 3
EFFECT OF SELENITE ON CHEMILUMINESCENCE AND GSH-Px ACTIVITY

Sample
#

Selenite
Dose
(/ig/ml)

1

0
0.1
0.5
1.0

1.20
1.71
1.56
1.61

±
±
±
±

0.14
0.03
0.08
0.03

0
0.1
0.5
1.0

2.74
3.40
3.73
3.24

±
±
±
±

0.19
0.16
0.17
0.04

0
0.1
0.5
1.0

3.47
4.63
4.17
2.78

±
±
±
±

0.24
0.38
0.17
0.04

0
0.1
0.5
1.0

4.82
4.55
5.49
2.22

±
±
±
±

0.80
0.41
0.30
0.10

0
0.1
0.5
1.0

3.33
3.14
3.07
3.26

±
±
±
±

0.25
0.44
0.10
0.02

2

3

4

5

Cla

Tukey's
HSD
Intervals

*

GSH-Pxb
Activity
(x 10“2)

Tukey's
HSD
Intervals

1.91
2.49
2.44
2.29

±
±
±
±

0.02
0.08
0.02
0.01

*

*
*
*

* *
*
*

1.44
1.47
1.54
1.49

±
±
±
±

0.01
0.01
0.02
0.03

*
* *

*

*
*
*
*
*
*
*

*

NS

1.60 ± 0.05
ND
2.21 ± 0.11
ND
3.36 ± 0.01
ND
4.41 ± 0.04
ND
1.43
1.44
1.41
1.50

±
±
±
±

0.01
0.04
0.05
0.08

*
*

*

*
*

p<0.04t

P<0.0lt

NS

Chemiluminescence expressed as mean integrated photon emission ± SEM
(x 107).
D^mole NADPH oxidized/min/mg/ml protein ± SEM.
tDetermined by Student's two-tailed t-test.
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Figure 1.

The effect of selenite on chemiluminescence exhibiting

significant (p<0.05) enhancement of chemiluminescence with all dosages
of selenite used.
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Figure 2.

The effect of selenite on chemiluminescence exhibiting

significant (p<0.05) enhancement of chemiluminescence with 0.1 and 0.5
/ig/ml selenite and significant (p<0.05) depression with 1.0 /xg/ml
selenite.
X 107.
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Figure 3.

The effect of selenite on chemiluminescence exhibiting

no significant changes with the addition of 0.1 and 0.5 jug/ml selenite
but significant enhancement with 1.0 /ig/ml selenite.
is expressed as integrated photon emission X 10
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Figure 4.

The effect of selenite on chemiluminescence exhibiting

significant (p<0.05) depression of chemiluminescence with 1.0 /xg/ml
selenite.

0.1 and 0.5 /xg/ml selenite had no affect on

chemiluminescence.
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Figure 5.

The effect of selenite on chemiluminescence exhibiting

no significant changes with the addition of all dosages of selenite
used.
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Figure 6.

The effect of selenite on NK cytotoxicity demonstrating

six different responses to in vitro selenite supplementation.
** represents significant (p<0.05) enhancement of activity.
f represents significant (p<0.05) suppression of activity.
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Discussion
This study demonstrates that the activities of human NK cells and
neutrophils were affected by in vitro incubation with sodium selenite.
These effects included augmentation and suppression of neutrophil CL
and NK-mediated cytotoxicity.

All dosages of selenite used were shown

to be capable of inducing augmentation of CL activity.

In some samples

of phagocytic cells, the addition of 1.0 /ig/ml selenite caused a
depression of phagocytic activity.

When Se supplementation enhanced NK

cytotoxicity, the effect was always observed at 0.1 /xg/ml selenite.

At

the two higher dosages used, selenite induced both enhancement and
depression of activity.

These results are in agreement with those

obtained from dietary Se supplementation of humans and animals.

Aziz

et al. (1) and Gyang et al (24) demonstrated a dose-dependent increase
in PMN function in goats and cows receiving Se supplementation.
Talcott et al. (7) and Koller et al. (5) both observed a dose-dependent
enhancement of NK activity in rats after in vivo supplementation with
Se.

Dimitrov et al. (3) demonstrated a similar dose-dependent

enhancement of NK activity in humans receiving a selenium supplement.
The findings of this study contradict those of Watson (29) and
Dimitrov (3).

Neither investigator observed significant augmentation

of NK activity with in vitro supplementation of sodium selenite.

These

authors did, however, observe significant depression of NK activity
when cells were incubated in vitro at selenite dosages of 1.0 /xg/ml or
greater.

The differences between these reports and the present study

may be due to the fact that Dimitrov's group employed an 18 hour
preincubation of mononuclear cells in selenite prior to performing the
NK cytotoxicity assay while Watson preincubated cells for 48 hours
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prior to the assay.

These long preincubations are in contrast to the

procedure employed in this study wherein selenite was added directly to
the effector-target wells at the start of the actual NK cytotoxicity
assay.

Moreover, Nabel (34) reported that NK cells undergo a loss of

activity in as few as 6 hours when maintained in vitro at 37°C.
During the course of this investigation, there were samples which
demonstrated no significant augmentation of phagocytic or NK activity
as a function of Se supplementation.

This perhaps reflects the

presence of ideal intracellular Se levels before treatment.

Depression

of NK cytotoxicity and neutrophil-mediated CL upon Se supplementation
may indicate Se toxicity resulting from an increase in intracellular Se
levels over ideal intracellular concentrations.

Though intracellular

and plasma Se levels were not evaluated in this study, this view finds
support in the literature.

Severe systemic Se toxicity has been

reported in the People's Republic of China in individuals whose whole
blood Se levels averaged 3200 ng/ml (35).

Severe Se toxicity was also

reported in a New York woman taking Se supplements containing 27.3 mg
per tablet (36).

Her serum Se level was reported as 528 ng/ml,

approximately four times the normal levels for the U.S. population.
The proposed adequate and safe daily dosage of Se is 50-200 /zg per day.
Serum Se levels much lower than those reported in individuals with
systemic Se toxicity have been found to cause immunotoxicity.

Dimitrov

(3) demonstrated increases in plasma Se levels from 0.11 /zg/ml to 0.12
/xg/ml were associated with increases in NK cytotoxicity.

However,

increases in plasma Se levels beyond 0.12 ng/ml began to depress
activity.

A narrow dosage-window appears to be evident.

Therefore
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caution should be exercised in recommending Se supplementation.

Tests

evaluating immune function or intracellular Se levels may be valuable
in deciding whether supplementation is warranted.
Previous investigators have demonstrated that Se deficient animals
exhibited a marked reduction in phagocytic intracellular killing with a
corresponding reduction in the activity of the selenoenzyme GSH-Px
(1,2,4,25).

In animals, the level of phagocyte GSH-Px activity appears

to be directly dependent upon the Se concentration in the phagocyte's
environment (1).

The present study of human neutrophils is in

agreement with the results obtained in animals.

Dose-dependent

augmentation of CL by in vitro selenite supplementation was accompanied
by a corresponding increase in phagocyte GSH-Px activity.

Conversely,

no dose-related changes in GSH-Px levels were observed in neutrophils
which exhibited no change in CL as a function of selenite treatment.
The view that selenium-enhanced phagocytic activity is mediated via
GSH-Px (1) is sustained by these data.
In addition to the anti-oxidant role of GSH-Px, this enzyme has
been demonstrated to be closely coupled to arachidonic acid
metabolism (37-40).

Since NK activity is dependent upon arachidonic

acid metabolism (41), a correlation between selenium-enhanced NK
activity and intracellular GSH-Px levels was sought.

Addition of

selenite to non-adherent cells had effects on GSH-Px activity which did
not correlate with previously determined NK activity.

This suggests

that GSH-Px may not be involved in selenite-induced enhancement of NK
cytotoxicity.

Further investigation is therefore warranted.
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